Cloud-based platform enables use of AI on medical images
FDA clears Arterys MICA platform for use on cardiac patients, with other approvals pending, says Fabien Beckers.
The Food and Drug Administration has approved Arterys’ web-based imaging analytics platform, which marries cloud-based supercomputing and artificial intelligence, for clinical use.
The FDA approval allows the Arterys product, called MICA, to supply clinical guidance to clinicians treating cardiac patients. The company is awaiting FDA clearance that would allow the platform to be used by oncology teams treating patients with lung and liver conditions.
Also See: NTT Data platform applies analytics, AI to images within workflows
MICA is web-based and runs on a scalable distributed graphics processing architecture, enabling the product to apply various AI algorithms to image studies of specific cases. This addresses one of the major challenges of applying a variety of algorithms that use artificial intelligence to imaging studies—intelligently calling upon the right algorithm to provide guidance to clinicians while they are investigating a case or making treatment decisions.
The FDA approval will allow organizations to deploy the solution to enable clinicians to use it in real time while they are delivering care to patients. Doctors can apply artificial intelligence to images while they are in the process of delivering care or making decisions about what treatment course to pursue.
"The Arterys MICA platform realizes our vision of democratizing high-quality care via data-driven medicine and assisting radiologists across a wide variety of workflows," said CEO and co-founder Fabien Beckers. "The platform and these products get us one step closer to our vision of empowering physicians with AI to convert data into insights so they can define the optimal path for each of their patients."
The company says MICA can support multiple workflows in a variety of imaging modalities, such as MRI and CT. It was designed to work seamlessly with applications that integrate AI algorithms into workflows, enabling clinicians to interact with and edit their output in real time. The system also captures these user edits, so that algorithms can later be improved based on real-world use, creating collective intelligence that can benefit all users.
The cloud provides several additional benefits, including scalability without additional IT investment, access to the latest updates and upgrades to the product, and the ability to share images of any size easily and with a complete set of interpretation tools.
The FDA approval allows the Arterys product, called MICA, to supply clinical guidance to clinicians treating cardiac patients. The company is awaiting FDA clearance that would allow the platform to be used by oncology teams treating patients with lung and liver conditions.
Also See: NTT Data platform applies analytics, AI to images within workflows
MICA is web-based and runs on a scalable distributed graphics processing architecture, enabling the product to apply various AI algorithms to image studies of specific cases. This addresses one of the major challenges of applying a variety of algorithms that use artificial intelligence to imaging studies—intelligently calling upon the right algorithm to provide guidance to clinicians while they are investigating a case or making treatment decisions.
The FDA approval will allow organizations to deploy the solution to enable clinicians to use it in real time while they are delivering care to patients. Doctors can apply artificial intelligence to images while they are in the process of delivering care or making decisions about what treatment course to pursue.
"The Arterys MICA platform realizes our vision of democratizing high-quality care via data-driven medicine and assisting radiologists across a wide variety of workflows," said CEO and co-founder Fabien Beckers. "The platform and these products get us one step closer to our vision of empowering physicians with AI to convert data into insights so they can define the optimal path for each of their patients."
The company says MICA can support multiple workflows in a variety of imaging modalities, such as MRI and CT. It was designed to work seamlessly with applications that integrate AI algorithms into workflows, enabling clinicians to interact with and edit their output in real time. The system also captures these user edits, so that algorithms can later be improved based on real-world use, creating collective intelligence that can benefit all users.The cloud provides several additional benefits, including scalability without additional IT investment, access to the latest updates and upgrades to the product, and the ability to share images of any size easily and with a complete set of interpretation tools.
More for you
Loading data for hdm_tax_topic #better-outcomes...